Respective roles of factors II, VII, IX, and X in the procoagulant activity of FEIBA.

Abstract

Activated prothrombin complex concentrates (APCCs) are effective in the therapy of bleeding episodes in hemophilic patients with inhibitors. We investigated the respective roles of factor II, factor VII, factor IX, and factor X in the procoagulant activity of the APCC FEIBA. Factor II, factor VII, factor IX, and factor X were reduced in platelet-poor plasma, and the thrombin potential (TP) was determined using a chromogenic substrate in the absence or presence of FEIBA. Reduction of factor II resulted in a significant decrease of the TP without influencing the lag phase until the onset of thrombin generation. The reduction of factor VII showed no effect on the TP, but resulted in a prolongation of the lag phase. Changes of factor IX or factor X concentrations showed neither an effect on the TP nor on lag phases. Our study demonstrates that thrombin generation in the presence of FEIBA mainly depends on prothrombin.

• Authors: S Gallistl, G Cvirn, B Leschnik, W Muntean
• Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis (Blood Coagul Fibrinolysis) Vol. 13 Issue 7 Pg. 653-5 (Oct 2002) ISSN: 0957-5235 [Print] England
• PMID: 12439153 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Blood Coagulation Factors
• Factor VII
• Prothrombin
• Factor IX
• Factor X
• anti-inhibitor coagulant complex
• Thrombin

Topics

• Blood Coagulation Factors (pharmacology, physiology)
• Factor IX (physiology)
• Factor VII (physiology)
• Factor X (physiology)
• Hemostasis (drug effects)
• Humans
• Prothrombin (physiology)
• Thrombin (biosynthesis, drug effects)
• Thrombophilia